RAPP - Company ID 0002012593
As of 2026-09-07, Rapport Therapeutics, Inc. (RAPP) has a market capitalization of $2.19 B, making it the #2079 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-07 | $2.19 B |
| 2026-09-06 | $2.19 B |
| 2026-09-05 | $2.19 B |
| 2026-09-04 | $2.19 B |
| 2026-09-03 | $2.28 B |
| 2026-09-02 | $2.33 B |
| 2026-09-01 | $2.34 B |
| 2026-08-31 | $2.33 B |
| 2026-08-30 | $2.33 B |
| 2026-08-29 | $2.33 B |
| 2026-08-28 | $2.33 B |
| 2026-08-27 | $2.43 B |
As of 2026-09-07, Rapport Therapeutics, Inc. (RAPP) has a market capitalization of $2.19 B, making it the #2079 most valuable US-listed company.
Rapport Therapeutics, Inc. is the #2079 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-26 | $2.51 B |
| 2026-08-25 | $2.45 B |
| 2026-08-24 | $2.36 B |
| 2026-08-23 | $2.31 B |
| 2026-08-22 | $2.31 B |
| 2026-08-21 | $2.31 B |
| 2026-08-20 | $2.31 B |
| 2026-08-19 | $2.35 B |
| 2026-08-18 | $2.32 B |
| 2026-08-17 | $2.32 B |
| 2026-08-16 | $2.27 B |
| 2026-08-15 | $2.27 B |
| 2026-08-14 | $2.27 B |
| 2026-08-13 | $2.31 B |
| 2026-08-12 | $2.28 B |
| 2026-08-11 | $2.31 B |
| 2026-08-10 | $2.25 B |
| 2026-08-09 | $2.18 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.